I
IGC Pharma, Inc. (IGC)
ASE – Real Time Price. Currency in USD
0.26
+0.00 (0.42%)
At close: Jun 26, 2026, 4:00 PM EDT
0.27
+0.01 (2.66%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
0.26
+0.00 (0.42%)
At close: Jun 26, 2026, 4:00 PM EDT
0.27
+0.01 (2.66%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Total debt $926.0K significantly exceeds cash reserves ($207.0K), raising financial stability concerns
Total current liabilities $2.9M surpass Total current assets $1.1M, signaling liquidity issues
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.40 | 6.05 | 4.0 | |
| Quick ratio | 0.17 | 5.63 | 2.0 | |
| Debt to Equity | 0.15 | 0.30 | 9.0 | |
| Debt to Assets | 0.10 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 397K | 911K | 1M | 1M | 1M |
| Gross Profit | -433K | -158K | 170K | 52K | 28K |
| Operating Income | -15M | -12M | -10M | -7M | -10M |
| Net Income | -15M | -12M | -13M | -7M | -7M |
| EBITDA | -15M | -11M | -9M | -7M | -10M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -14.14 | 0 | 1.0 |
| Next quarter | N/A | -100 | 1.0 |
| Current year | -1.38 | -80 | 1.0 |
| Next year | 0 | 11.11 | 4.0 |
| Weighted average score | 1.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -9.42 | -230.84 | -99.99 | 0.89 | 1.3 |
| Y/Y | -3.93 | -100.66 | 0 | -63.63 | 1.0 |
| 3y average | 57.21 | 18.54 | N/A | 13.2 | 7.0 |
| 5y average | 7.58 | -7.03 | N/A | 16.64 | 4.3 |
| Weighted average score | 3.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |